Jyong Biotech, a biotech company based in Taiwan, has noticed some unusual activity in its stock price and trading volume. This comes just after a lock-up period ended this month. The company is in talks with some investment funds about buying shares, but they say they're not hiding any big news tha
Genenta Science, a company working on new ways to fight cancer, has some news to share. Their CEO, Pierluigi Paracchi, has been buying up shares of the company. Over time, he's picked up 30, 000 American Depositary Shares, or ADSs, through open-market purchases. No sales have been reported, just buy
In the world of medical research, a new player has emerged that could change the game for people with a tough type of blood cancer called acute myeloid leukemia (AML). This cancer is notorious for being resistant to many treatments, especially in cases with complex genetic issues like MECOM rearrang
Parents of kids with disruptive behavior disorders often feel lost. They struggle to manage outbursts. But what if technology could lend a hand? Researchers have been exploring this idea. They want to know if digital tools can help. Specifically, tools that give real-time feedback. These tools coul
Pets are family, and just like humans, they can struggle with weight issues. A new study is exploring a way to help cats keep their weight in check. The study is testing a small implant that slowly releases a weight loss drug over six months. This isn't just about looks; it's about health. Overweigh
Xenotransplantation, or the process of transplanting organs from animals to humans, has made significant progress. Scientists are now planning clinical trials, but there's a big question: will people be okay with it? Understanding what people think about this is crucial. Without public support, the
High blood pressure is a big problem for many people. A new treatment called kidney denervation might help. It is a small operation where doctors use a tiny tube to target nerves around the kidneys. This is done to lower blood pressure. The U. S. FDA has given the green light to this treatment. Doc
Multiple myeloma is a tough cancer to beat. It's sneaky, it comes back often, and it gets resistant to treatments. But in the last 20 years, scientists have been working hard to find new ways to fight it. They've come up with some pretty cool stuff. There are new drugs that target specific parts of
A recent study has brought disappointing news for those hoping to combat Alzheimer's disease. The drug semaglutide, known for its effectiveness in managing diabetes and obesity, did not show any significant benefits in slowing down the progression of Alzheimer's. This was revealed in two large-scale
People with type 2 diabetes often struggle to manage their blood sugar levels. But what if technology could lend a hand? A recent study explored this idea by testing two tools: continuous glucose monitors (CGM) and exercise trackers like Fitbit. The goal was to see if using these devices together co
